JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TNGX Financials - Tango Therapeutics Income & Cash Flow | Ledgeburg
TNGX - Tango Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TNGX Stock
Financials
Financials TNGX Stock
Loading...
Loading...
Income Statement
Income Statement TNGX Stock
Balance Sheet
Balance Sheet TNGX Stock
Cash Flow Statement
Cash Flow Statement TNGX Stock
Loading...
Loading...
Home
Stocks
Tango Therapeutics, Inc. (TNGX)
Financials
Financials of TNGX
Loading...
Loading...
Loading...
Loading...
Revenue
$62.384M
Operating Income
$-111.289M
Net Income
$-101.594M
Share Count (Basic)
116.166187M
Operating Cash Flow
$-138.886M
Free Cash Flow
$-139.934M
Cash And Short-Term Equivalents
$343.138M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
10M
20M
30M
40M
50M
Q1 FY25
Q2 FY25
Q3 FY25
Annual
Quarterly
Net Income $USD
-140M
-120M
-100M
-80M
-60M
Annual
Quarterly
Margins
Gross
Operating
Net
-500%
-400%
-300%
-200%
-100%
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-20M
0
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26